Home » Newsletters » BioWorld

BioWorld

Aug. 17, 1995

View Archived Issues

IMMULOGIC REGISTERS TO SELL 1M SHARES TO RAISE $10.5M

KEY PLAYERS IN FDA REFORM OVERSHADOW FRINGE GROUPS

CORRECTIONS

SERONO'S NON-APPROVED GROWTH HORMONE ADDED

OTHER NEWS TO NOTE

DEPOTECH, CHIRON REPORT POSITIVE RESULTS FOR CANCER DRUG

SCIENCE SCAN

ALKERMES REGISTERS TO SELL 2M SHARES TO RAISE $14.5M

MAGAININ CONTINUES BIOTECH'S HOT STREAK RAISING $33M

BRISTOL-MYERS, SIBIA TEAM UP ON ALZHEIMER'S RESEARCH

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...